Researchers in Japan have developed a novel technique to swiftly produce lung alveolar epithelial type 2-like cells from mouse embryonic fibroblasts without employing stem cell technologies. This accelerated protocol reduces differentiation time to 7–10 days compared to the month typically required with conventional methods. Such advancements promise to expedite pulmonary disease modeling and therapeutic development.